A predictive model of the economic effects of an influenza vaccine adjuvant for the older adult (age 65 and over) population

This publication has 43 references indexed in Scilit:

• MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18–60 years of age) with chronic diseases who are at risk of post-influenza complications
  Vaccine, 2007
• The Boomers Are Coming: A Total Cost of Care Model of The Impact of Population Aging on The Cost of Chronic Conditions in The United States
  Disease Management, 2007
• Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial
  The Lancet, 2006
• The Boomers Are Coming: A Total Cost of Care Model of the Impact of Population Aging on Health Care Costs in the United States by Major Practice Category
  Health Services Research, 2006
• Vaccines for preventing influenza in the elderly
  Published by Wiley ,2006
• The unmet need in the elderly: Designing new influenza vaccines for older adults
  Vaccine, 2005
• Influenza
  The Lancet, 2003
• Toward Consistency in Cost-Utility Analyses
  Medical Care, 1998
• Clinical effectiveness of influenza vaccination in Manitoba
  Published by American Medical Association (AMA) ,1993
• The utility of different health states as perceived by the general public
  Journal of Chronic Diseases, 1978